Labelled Oligonucleotides as Radiopharmaceuticals: Pitfalls, Problems and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|16|1451-1466

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.16, 2002-07, pp. : 1451-1466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Automation for Optimised Production of Fluorine-18-Labelled Radiopharmaceuticals

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 3, 2010-07 ,pp. : 248-253

Bentham Science Publishers

Access to resources Recommend Favorite

Astatine Radiopharmaceuticals: Prospects and Problems

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 177-196

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 1, 2018-04 ,pp. : 22-33

Bentham Science Publishers

Access to resources Recommend Favorite

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 156-172

Bentham Science Publishers

Access to resources Recommend Favorite

Radiobromine-Labelled Tracers for Positron Emission Tomography: Possibilities and Pitfalls

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 2, 2011-04 ,pp. : 76-89

Bentham Science Publishers

Access to resources Recommend Favorite